Zhongji Holdings

Zhongji Longevity Science Group Limited is a Hong Kong-listed company dedicated to the advancement of longevity science and personalized healthcare. The group operates through three primary segments: longevity biological science, longevity medicine, and longevity management, offering a range of products including NMN (Nicotinamide Mononucleotide) supplements and services such as immune cell storage and cancer screening. By integrating cutting-edge biotechnology with clinical applications, Zhongji aims to provide comprehensive solutions for life extension and disease prevention. The company maintains a global presence with medical centers and research partnerships focused on optimizing human healthspan and wellness. Through its public listing on the Hong Kong Stock Exchange, the group continues to expand its footprint in the anti-aging and preventive medicine markets.